Literature DB >> 16798515

Current concepts: treatment of osteochondral ankle defects.

Maartje Zengerink1, Imre Szerb, László Hangody, Ryan M Dopirak, Richard D Ferkel, C Niek van Dijk.   

Abstract

Osteochondral ankle defects cause various symptoms including pain, swelling, and limited range of motion. When surgical treatment is necessary, several treatment options exist. Arthroscopic debridement and drilling, arthroscopic autologous osteochondral transplantation (mosaiclasty), and autologous chondrocyte transplantation are discussed more extensively. Treatment results of each technique are discussed, and a guideline for treatment is presented.

Entities:  

Mesh：

Year:  2006        PMID： 16798515     DOI： 10.1016/j.fcl.2006.03.008

Source DB:  PubMed          Journal:  Foot Ankle Clin        ISSN： 1083-7515            Impact factor:   1.653


  25 in total

1.  Large variation in management of talar osteochondral lesions among foot and ankle surgeons: results from an international survey.

Authors:  Matteo Guelfi; Christopher W DiGiovanni; James Calder; Francesc Malagelada; Guillaume Cordier; Masato Takao; Jorge Batista; Caio Nery; Marino Delmi; Miki Dalmau-Pastor; Giovanni Carcuro; Gabriel Khazen; Jordi Vega
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-11-22       Impact factor: 4.342

2.  Treatment of osteochondral lesions of the talus with microfracture technique and postoperative hyaluronan injection.

Authors:  M N Doral; O Bilge; G Batmaz; G Donmez; E Turhan; M Demirel; O A Atay; A Uzumcugil; K Atesok; D Kaya
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-12-29       Impact factor: 4.342

3.  Potential pitfall in the microfracturing technique during the arthroscopic treatment of an osteochondral lesion.

Authors:  Christiaan J A van Bergen; Peter A J de Leeuw; C Niek van Dijk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-09-23       Impact factor: 4.342

4.  Cell quality affects clinical outcome after MACI procedure for cartilage injury of the knee.

Authors:  Matthias F Pietschmann; Annie Horng; Thomas Niethammer; Isa Pagenstert; Birte Sievers; Volkmar Jansson; Christian Glaser; Peter E Müller
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-06-10       Impact factor: 4.342

5.  Pulsed electromagnetic fields after arthroscopic treatment for osteochondral defects of the talus: double-blind randomized controlled multicenter trial.

Authors:  Christiaan J A van Bergen; Leendert Blankevoort; Rob J de Haan; Inger N Sierevelt; Duncan E Meuffels; Pieter R N d'Hooghe; Rover Krips; Geert van Damme; C Niek van Dijk
Journal:  BMC Musculoskelet Disord       Date:  2009-07-10       Impact factor: 2.362

Review 6.  Rehabilitation and return-to-sports activity after debridement and bone marrow stimulation of osteochondral talar defects.

Authors:  Inge C M van Eekeren; Mikel L Reilingh; C Niek van Dijk
Journal:  Sports Med       Date:  2012-10-01       Impact factor: 11.136

Review 7.  Cartilage repair techniques of the talus: An update.

Authors:  Mike H Baums; Wolfgang Schultz; Tanja Kostuj; Hans-Michael Klinger
Journal:  World J Orthop       Date:  2014-07-18

8.  An anterior ankle arthroscopic technique for retrograde osteochondral autograft transplantation of posteromedial and central talar dome cartilage defects.

Authors:  Anthony Wajsfisz; Konstantinos G Makridis; Omar Naji; Caroline Hirsh; Philippe Boisrenoult; Philippe Beaufils
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-04-12       Impact factor: 4.342

9.  A soccer player with idiopathic osteonecrosis of the complete lateral talar dome: a case report.

Authors:  Job N Doornberg; Peter A J de Leeuw; Maartje Zengerink; C Niek van Dijk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-05-07       Impact factor: 4.342

Review 10.  Treatment of osteochondral lesions of the talus: a systematic review.

Authors:  Maartje Zengerink; Peter A A Struijs; Johannes L Tol; Cornelis Niek van Dijk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-10-27       Impact factor: 4.342
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.